Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients von Trümpelmann, Susan, Schulte‐Mecklenbeck, Andreas, Steinberg, Olga V., Wirth, Timo, Fobker, Manfred, Lohmann, Lisa, Lünemann, Jan D., Wiendl, Heinz, Gross, Catharina C., Klotz, Luisa

Volltext